Id Biomedical Corporation

Id Biomedical Corporation of Quebec

Shire Biochem, Inc.

Stephane Rioux

Bernard R. Brodeur

Josee Hamel

Denis Martin

Martine Boyer

Bernard R Brodeur

Josée Hamel

Isabelle Charlebois

Stéphane Rioux

Clément Rioux

Clement Rioux

Group B(GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy ofinfection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detectingbacterial infection.

[object Object]

Group B(GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.

Group B streptococcus antigens

The present invention relates to antigens, more particularly an antigen of(also called group A(GAS)) bacterial pathogen which is useful as vaccine component for therapy and/or prophylaxis.

The present invention relates to antigens, more particularly antigens of Group B(GBS) () which may be useful to prevent, diagnose and/or treat streptococcal infections.

Group Bpolypeptides and polynucleotides encoding them are disclosed. Said polypeptides may be useful for the prophylaxis, diagnostic and/or therapy of streptococcal infection in mammals. Also disclosed are recombinant methods of producing the polypeptide antigens as well as diagnostic assays for detecting streptococcal infections, particularly GBS.

Growing community of inventors

Ste-Foy, Canada

Martine Boyer